Learning Objectives:

  • Identify therapy-related leukemia as a long-term complication of multiple myeloma therapies
  • Recognize possible mechanisms driving therapy-related leukemia in multiple myeloma 
  • Discuss investigations aimed at identifying patients at high risk for therapy-related leukemia
Session date: 
10/02/2023 - 12:00pm to 1:00pm CDT
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Jennifer Cooperrider, MD